Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 149-168.e17
Open Access | Times Cited: 1237

Showing 1-25 of 1237 citing articles:

NLRP3 inflammasome in cancer and metabolic diseases
Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Nature Immunology (2021) Vol. 22, Iss. 5, pp. 550-559
Open Access | Times Cited: 712
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Toni Delorey, Carly G.K. Ziegler, Graham Heimberg, et al.
Nature (2021) Vol. 595, Iss. 7865, pp. 107-113
Open Access | Times Cited: 710
SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 685
COVID-19 and the human innate immune system
Joachim L. Schultze, Anna C. Aschenbrenner
Cell (2021) Vol. 184, Iss. 7, pp. 1671-1692
Open Access | Times Cited: 661
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 494
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines
Min Zheng, Rajendra Karki, Evan P. Williams, et al.
Nature Immunology (2021) Vol. 22, Iss. 7, pp. 829-838
Open Access | Times Cited: 491
CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
Peng Liao, Weimin Wang, Weichao Wang, et al.
Cancer Cell (2022) Vol. 40, Iss. 4, pp. 365-378.e6
Open Access | Times Cited: 483
Death by TNF: a road to inflammation
Geert Loo, Mathieu J.M. Bertrand
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 289-303
Open Access | Times Cited: 450
Inflammation and aging: signaling pathways and intervention therapies
Xia Li, Chentao Li, Wanying Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 437
AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence
SangJoon Lee, Rajendra Karki, Yaqiu Wang, et al.
Nature (2021) Vol. 597, Iss. 7876, pp. 415-419
Open Access | Times Cited: 415
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1804-1820.e16
Open Access | Times Cited: 349
From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways
Yaqiu Wang, Thirumala‐Devi Kanneganti
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4641-4657
Open Access | Times Cited: 312
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Shea A. Lowery, Alan Sariol, Stanley Perlman
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1052-1062
Open Access | Times Cited: 259
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Rajendra Karki, Thirumala‐Devi Kanneganti
Trends in Immunology (2021) Vol. 42, Iss. 8, pp. 681-705
Open Access | Times Cited: 254
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
Rajendra Karki, Balamurugan Sundaram, Bhesh Raj Sharma, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109858-109858
Open Access | Times Cited: 248
Monocytes and Macrophages in COVID-19
Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 235
The interferon landscape along the respiratory tract impacts the severity of COVID-19
Benedetta Sposito, Achille Broggi, Laura Pandolfi, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4953-4968.e16
Open Access | Times Cited: 233
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 206
Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
Bindu D. Paul, Marian Dix Lemle, Anthony L. Komaroff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 34
Open Access | Times Cited: 200
Programmed Cell Death Tunes Tumor Immunity
Jing Liu, Minjing Hong, Yijia Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 199
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 196
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Immunity (2021) Vol. 54, Iss. 11, pp. 2650-2669.e14
Open Access | Times Cited: 192
Programming inflammatory cell death for therapy
Shelbi Christgen, Rebecca E. Tweedell, Thirumala‐Devi Kanneganti
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108010-108010
Open Access | Times Cited: 191
Page 1 - Next Page

Scroll to top